Results 51 to 60 of about 7,728 (235)

Regional variations and temporal trends of atopic diseases in Germany

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Prevalence rates of atopic diseases (atopic dermatitis [AD], allergic asthma [AA], and allergic rhinoconjunctivitis [ARC]) have increased in Germany. However, there is a lack of simultaneous consideration and of precise data on the spatiotemporal variation of these diseases.
Marie Sander, Matthias Augustin, Valerie Andrees, Sandra Hischke, Jobst Augustin   +4 more
wiley   +1 more source

Long-term dupilumab treatment for chronic refractory generalized prurigo nodularis: A retrospective cohort study [PDF]

, 2021
Jorge R. Georgakopoulos, David Croitoru, Tina Felfeli, Raed Alhusayen, Perla Lansang, Neil H. Shear, Jensen Yeung, Scott R. Walsh   +7 more
openalex   +1 more source

Prurigo pigmentoso

Actas Dermo-Sifiliográficas, 2005
Prurigo pigmentosa is an infrequent inflammatory dermatosis of unknown etiology, characterized by recurrent episodes of pruritic erythematous papules which develop into intense reticulated pigmentation. It has been referenced most frequently in young women in Japan. Only thirty cases have been described outside of Japan.
Eloy, Rodríguez-Díaz, Susana, Blanco, César, Alvarez-Cuesta, Cristina, Galache, Armando, Barrio, Gabriela, Corte   +5 more
openaire   +2 more sources

Chronic Prurigo

JDDG: Journal der Deutschen Dermatologischen Gesellschaft
SummaryChronic prurigo (CPG) is a neuroinflammatory dermatosis characterized by prolonged pruritus lasting more than 6 weeks, pruriginous skin lesions, and repeated scratching.Patients with CPG suffer significantly from psychological distress and a marked impairment in their quality of life.
Julia Thünemann, Svenja Müller, Kerstin Steinbrink, Sonja Ständer, Claudia Zeidler   +4 more
openaire   +2 more sources

Minimal Disease Activity as A New Therapeutic Target in Atopic Dermatitis: A 5‐Year Real‐Life Experience With Dupilumab

International Journal of Dermatology, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease with significant physical and psychosocial burden. Dupilumab, a monoclonal antibody targeting IL‐4Rα, has proven to be effective for moderate‐to‐severe AD, but long‐term real‐world data remain limited.
Francesco Leo, Luca Mastorino, Luca Cangialosi, Davide Favre, Chiara Anna Fiasconaro, Yingying Liao, Federico Goso, Niccolò Siliquini, Giovanni Cavaliere, Pietro Quaglino, Simone Ribero, Michela Ortoncelli   +11 more
wiley   +1 more source

Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Dermatophyte infections of the dermis and subcutaneous tissue (i.e. deep dermatophytosis)—associated with secondary complications including pseudomycetoma and systemic dissemination—affect vulnerable populations with primary or acquired immunodeficiencies.
Aditya K. Gupta, Tong Wang, Susmita, Ditte Marie L. Saunte, Roderick Hay, Vincent Piguet   +5 more
wiley   +1 more source

Expressions of Interleukin-4 and Interleukin-5 in Nodular Prurigo and Pruritic Papular Lesions

Folia Medica Indonesiana
Highlights: 1. An examination of IL-4 and IL-5 expressions in nodular prurigo and pruritic papular eruption is crucial for enhancing the effectiveness of biological agent therapy, specifically for HIV/AIDS patients. 2.
Ayu Wikan Sayekti, Ann Kautsaria Putri, Dwi Retno Adi Winarni, Satiti Retno Pudjiati   +3 more
doaj   +1 more source

Dementia Incidence in Patients With Prurigo Nodularis: An Observational Retrospective Cohort Study

JEADV Clinical Practice, EarlyView.
Madison P. Olexson, Ana Ormaza Vera, Chunghwan Ro, Clinton W. Enos   +3 more
wiley   +1 more source

The SWITCH algorithm: An expert consensus on treat‐to‐target criteria for chronic prurigo

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The SWITCH project assessed patients' most distressing symptoms and therapy goals, followed by an expert‐based consensus procedure to define T2T criteria for patients with chronic prurigo (CPG)/prurigo nodularis. Based on these validated criteria, a 4‐step SWITCH algorithm was established to enhance CPG therapy outcomes and reduce patient burden ...
Lea S. Stahl, Claudia Zeidler, Joyce Loewenthal, Svenja Royeck, Matthias Augustin, Robert Bissonnette, Sarina Elmariah, Brian S. Kim, Laurent Misery, Hiroyuki Murota, Hong Liang Tey, Elke Weisshaar, Gil Yosipovitch, Franz J. Legat, Adam Reich, Martin Metz, Sonja Ständer   +16 more
wiley   +1 more source

Successful treatment of refractory prurigo nodularis with abrocitinib

Clinical Case Reports
Key Clinical Message Prurigo nodularis is frequently difficult to manage with conventional therapy. Given the pathogenesis and refractory nature, we demonstrate a case in which inhibition of JAK–STAT signaling may significantly improve prurigo nodularis.
Fang Sun, Zhenzhen Wu
doaj   +1 more source